Growing evidence suggests a close association of plaque angiogenesis with atherosclerotic plaque formation and progression, and an important role of matrix metalloproteinase (MMP) in angiogenesis and atherosclerosis. We attempted to investigate the functional involvements of MMP8 in angiogenesis.
endothelial cell sprouting, and endothelial cells in MMP8 2/2 /apoE 2/2 mice had a lower ability to migrate into Matrigel plugs and less capacity of proliferation and angiogenesis. Moreover, immunohistochemical analyses revealed that MMP8 was expressed in microvessels within human atherosclerotic plaques and aneurysm. Finally, analyses of MMP8 2/2 / apoE 2/2 and MMP8 +/+ /apoE 2/2 mice fed a Western diet for 12 weeks showed that MMP8-deficient mice had small lesion size and less endothelial cells within atherosclerotic lesions.
Conclusion
We demonstrated for the first time that MMP8 plays an important role in angiogenesis in vitro and in vivo. Our findings provide new insights into the molecular mechanisms of plaque angiogenesis and suggest that MMP8 is a potential therapeutic target of cardiovascular diseases.
Introduction
Angiogenesis, characterized by the growth of new blood vessels or new capillaries from pre-existing vessels, plays an essential role during embryonic development as well as in the postnatal tissue remodelling under physiological or pathological conditions. Angiogenesis is a highly regulated process including the degradation of the extracellular matrix (ECM) within basement membrane by both soluble and cell-bound matrix metalloproteinases (MMPs), disruption of endothelial junction, endothelial proliferation and migration, tube formation with an encased lumen sealed by tight cell -cell junctions, synthesis of ECM proteins and the establishment of the new basement membrane, and the recruitment of mural cells stabilizing new connections. 1 Moreover, growing evidence suggests that plaque angiogenesis plays an important role in atherosclerotic plaque growth and transition by enhancing macrophage infiltration, promoting the transport † C.F. and G.W. contributed equally to this study. ‡ Q.X. and S.Y. share the senior authorship.
of erythrocyte-derived cholesterol in the lipid core, accelerating the progress of atherosclerosis and finally causing intraplaque haemorrhage. 2 Despite the huge therapeutic potential in cardiovascular diseases of modulating plaque angiogenesis levels in plaques having been recently proposed, few direct mediators or signal pathways of plaque angiogenesis have been identified. MMPs, a group of zinc-dependent proteinases consists of 28 family members, play important roles in ECM degradation 3 as well as in the cleavage of other proteins such as growth factor and cytokines. 4 MMPs have been implicated in physiological and pathological angiogenesis because of its fundamental nature in ECM metabolism and remodelling. To initiate angiogenesis, ECM surrounding endothelial cells must be first degraded by proteases to allow endothelial cell to migrate and various angiogenesis promoters and inhibitors such as growth factors, chemokines, growth factor receptors, adhesion molecules, and apoptosis mediators to be released from ECM. It has been reported that the activity of MMPs on such promoters or inhibitors is essential for angiogenesis. 5 In this context, previous evidence suggests that MMP14 is a particularly important regulator of endothelial cell migration and lumen formation within the ECM by regulating capillary sprouting, collagenolysis, and endothelial cell invasion. 6, 7 MMP7 has also been reported as an important regulator in angiogenesis by promoting endothelial proliferation. 8 Interestingly, another MMP, MMP9, has been shown to play a dual pro-and anti-angiogenic role, 9,10 suggesting a complex relationship between MMPs and angiogenesis. By generating MMP8 and ApoE double knockout mice, we found that inactivating MMP8 significantly reduces the sizes of atherosclerotic plaques with decreased macrophage infiltration and an increased collagen content, 4 which suggests an important role of MMP8 in atherosclerotic lesion progression. Most recently, we also demonstrated for the first time that MMP8 plays a crucial role in stem cell migration into atherosclerotic lesions, and its activation in stem cells promotes lesion development. 11 However, no evidence has been reported that MMP8 plays any role in angiogenesis in vitro and in vivo.
In the present study, we are the first to report that less endothelial cells or plaque angiogenesis was observed in the atherosclerotic plaques of MMP8 knockout mice, and provide evidence to show that MMP-8 plays an important role in EC angiogenesis in vitro, ex vivo, and in vivo by regulating the conversion of Ang I to Ang II, PECAM-1 expression, b-catenin nuclear accumulation and cell proliferation/migration-related gene expression.
Methods
A detailed description of the materials and methods is provided in the Supplementary material online.
Immunohistochemical analysis in human atherosclerotic plaques
The protocol for studying atherosclerotic plaques was approved by the relevant institutional human ethics committee in accordance with the Declaration of Helsinki. Sections were incubated with an avidin/biotin blocking solution, a peroxidase blocking solution, and 10% swine serum. Thereafter, the sections were incubated with a MMP8 antibody, followed by incubation with a biotinylated swine anti-rabbit Ig secondary antibody, avidinconjugated horseradish peroxidase, then with 3,3
′ -diaminobenzidine (DAB) and subsequently with haematoxylin as counterstaining.
Animal experiments, anaesthesia and euthanasia
All experiments were conducted according to the Animals (Scientific Procedures) Act of 1986 (UK). In addition, the principles governing the care and treatment of animals, as stated in the Guide for the Care and Use of Laboratory Animals published by the National Academy of Sciences (eighth edition, 2011), were followed at all times during this study. For the microinjections of Matrigel or cells into mice, anaesthesia was induced using 100% O 2 /4% isoflurane, and was maintained throughout the injection by the administration of 100% O 2 /2% isoflurane. All mice were euthanized by placing them under deep anaesthesia with 100% O 2 /5% isoflurane, followed by decapitation.
Characterization of endothelial cells within atherosclerotic lesions
MMP8 knockout (MMP8 2/2 /apoE 2/2 ) mice (C57BL/6 background) and wild-type (MMP8 +/+ /apoE 2/2 ) controls (generated from littermates of MMP8 2/2 /apoE 2/2 mice) were generated in our previous study. 4 Frozen sections of the aortic roots with an atherosclerotic plaque of MMP8 +/+ /apoE 2/2 and MMP8 2/2 /apoE 2/2 mice were incubated with antibodies against PECAM-1/CD31 or VE-cadherin/CD144, followed by an incubation with appropriate secondary antibody conjugated horseradish peroxidase, then with DAB and subsequently with haematoxylin as counterstaining.
Cell culture and angiotensin (Ang) I/II treatments
Human umbilical vein endothelial cells (HuVECs) were cultured in the EC growth medium. In some experiments, HuVECs were subjected to serum starvation for 8 -12 h, followed by Ang I and II stimulation in the serumfree medium for the indicated times. Cells at passages 3 -8 were used in this study.
Capillary-like network formation assay
Matrigel was thawed at 48C overnight and added to 96-well plate (50 mL/ well), followed by 1 h of incubation at 378C to allow the Matrigel to polymerize. HuVECs (1.5 × 10 4 /well) were seeded into the Matrigel-coated plate and cultured in EC growth medium to form capillary-like networks.
MMP8 knockdown in HuVECs
Gene knockdown in cell cultures by shRNA lentivirus was performed as described previously. 11, 12 For lentiviral infection, HuVECs were plated 24 h prior to infection in flasks (T25) at 378C. One transducing unit per cell (or 5 × 10 6 /flask) of MMP8 shRNA or non-target shRNA virus were added with 10 mg/mL hexadimethrine bromide (H9268; Sigma). Viral constructs were incubated 36 -48 h with the cells before the media was replaced with complete media containing 2 mg/mL puromycin (P9620, Sigma). For selection of stable transductants, fresh media containing puromycin was added at 2 -3 day intervals for 10 days. Stably shRNA-infected cells with successful MMP8 knockdown ( 60%) as demonstrated by western blot analyses ( Figure 4B ) were maintained and used in the following experiments.
In vivo angiogenesis assay
Two sets of in vivo angiogenesis experiments were conducted in this study.
In the first set of experiments, HuVECs infected with MMP8 shRNA lentivirus and non-target lentivirus were labelled with PKH26 Red Fluorescent reagent (Sigma) according to manufacturer's instructions. Cells (10 6 in 50 mL) were mixed with 50 mL of Matrigel (Becton Dickinson Labware) at 48C, and subcutaneously injected into mice. In the second set of experiments, 100 mL of Matrigel containing 100 ng/mL VEGF165 was injected subcutaneously into wild-type and MMP8 knockout mice. After 13 days, MMP8 and angiogenesis mice were sacrificed and the implants (Matrigel plugs) were harvested, frozen in liquid nitrogen and prepared for H&E staining or used for the detection of PKH26-labelled cells or other cell markers by immunofluorescent staining.
Immunofluorescent staining
Frozen sections of Matrigel plugs and chamber-slides contained HuVECs were blocked with 10% normal serum in PBS, followed by incubation of primary antibodies and respective secondary antibodies conjugated with fluorescein isothiocyanate or tetramethylrhodamine-5-(and 6)-isothiocyanate.
Endothelial proliferation assay
Endothelial proliferation was evaluated using 5-bromo-2 ′ -deoxy-uridine (BrdU) Labeling and Detection Kit II (Roche) according to the manufacturer's instructions.
Endothelial migration assay (scratch wound assay)
HuVECs were grown in 12-well plates until 100% confluence. Afterwards, cells were wounded with a sterile pipette tip (200 mL) to cause initial wounds with constant diameter. After washing with PBS three times to remove any detached cells or debris, cells were cultured with fresh complete medium in the presence of 2 mM hydroxyurea (Sigma) to eliminate the possibility that the cell migration is dependent on proliferation. Photographs were taken at 0, 6, 9 and 24 h, respectively. The migration distance was measured using the Image J software.
Statistical analysis
Results are presented as mean + standard error of the mean (SEM). Statistical analysis was performed by SPSS 16.0 (SPSS, Inc., IL, USA). The Shapiro-Wilk normality test was used for checking the normality of the data. Two-tailed unpaired Student's t-test was used for comparisons between two groups, or one-way analysis of variance with a post hoc test of LSD was applied when more than two groups were compared if the data display a normal distribution. P , 0.05 was considered statistically significant.
Results

Knockdown of MMP8 significantly impairs the capacity of in vitro angiogenesis of HuVECs
To investigate whether MMP8 plays any role in EC angiogenesis, we first evaluated the effects of MMP8 on EC angiogenesis by using an in vitro Matrigel capillary-like network formation assay. Uninfected HuVECs or HuVECs infected with MMP8 shRNA or non-target shRNA lentivirus were seeded into Matrigel-coated 96-well plates and cultured in the EC growth medium. After culturing for 24 h, wellestablished vascular network-like structures were clearly observed in the uninfected HuVECs as well as in non-target shRNA lentivirus-infected HuVECs, but not in the HuVECs infected with MMP8 shRNA lentivirus ( Figure 1A ). Images were taken from each group and analysed using Image Pro Plus software. Data shown in Figure 1B revealed that the branch lengths, numbers, and branch points were significantly reduced by knockdown of endogenous MMP8 in HuVECs, suggesting that MMP8 plays an important role in EC angiogenesis.
Knockdown of MMP-8 inhibits EC migration and proliferation
Since endothelial migration and proliferation are two important processes during angiogenesis, we wondered if MMP8 mediated angiogenesis through modulating endothelial cell migration and/or proliferation. To this end, HuVECs infected with non-target or MMP8 shRNA lentivirus were subjected to scratch wound assay. The assay showed that knockdown of endogenous MMP-8 significantly inhibited the migration of HuVECs (Figure 2A) . The BrdU incorporation assay was conducted with HuVECs infected with non-target or MMP8 shRNA lentivirus by using a BrdU Labeling and Detection Kit II to examine the effects of MMP8 knockdown on EC proliferation. The experiment showed that HuVECs infected with MMP8 shRNA lentivirus had reduced proliferation ability, compared with HuVECs infected with non-target shRNA lentivirus ( Figure 2B) . Moreover, the percentage of Ki-67 positive cells in HuVECs infected with MMP-8 shRNA lentivirus was significantly lower than that of control HuVECs (Supplementary material online, Figure S1 and Figure 2C ), further confirming the important functional involvement of MMP8 in EC proliferation.
MMP8 mediates PECAM-1 gene expression by converting Ang I to Ang II
PECAM-1/CD31 has been implicated in angiogenesis and endothelial migration, 13 therefore, we wondered if PECAM-1 plays any role in MMP8-mediated endothelial angiogenesis. To this aim, we first determined the expression of PECAM-1 in HuVECs infected with nontarget or MMP8 shRNA lentivirus by western blot analyses. As shown in Figure 3A and B, the protein expression levels of PECAM-1 in HuVECs infected with non-target shRNA lentivirus were significantly higher than that in HuVECs infected with MMP8 shRNA lentivirus, suggesting that PECAM-1 might play a role in MMP8-mediated angiogenesis. Ang II has been implicated in atherosclerosis progression 14 and angiogenesis, 15 and MMP8 has been shown to cleave Ang I to produce Ang II in our and others' studies. 4, 16 Moreover, PECAM-1 protein expression levels were significantly up-regulated by Ang II-induced endothelial microparticle in HuVECs, 17 suggesting a role of Ang II in regulation of PECAM-1 gene expression. We, therefore, wondered if MMP8 mediates PECAM-1 protein expression through modulating Ang I to II conversion. To this end, HuVECs infected with non-target or MMP8 shRNA lentivirus were serum starvation for 12 h, followed by Ang I (10 nM) stimulation for 24 h or Ang II (10 nM) stimulation for 6, 16 and 24 h, respectively. The level of PECAM-1 was then determined by western blot analyses. As expected, PECAM-1 protein expression levels were significantly up-regulated by Ang II stimulation in both non-target shRNA and MMP-8 shRNA lentivirus-infected HuVECs ( Figure 3C ). However, we only observed a significant increase in PECAM-1 protein expression in HuVECs infected with non-target shRNA lentivirus in response to Ang I stimulation ( Figure 3D ). Taken together, these data strongly suggest that Ang II converted from Ang I by MMP8 is responsible for MMP8-mediated PECAM-1 up-regulation in HuVECs.
MMP8 regulates cell proliferation-related gene expression by increasing b-catenin nuclear accumulation
b-Catenin as a mediator of the Wnt signalling pathway is involved in cell differentiation and proliferation in the development of cancer or embrogenesis, 18 while PECAM-1 has been reported to stimulate EC proliferation by up-regulating b-catenin expression and increasing its nuclear accumulation. 19 We, therefore, further wondered if MMP8
knockdown affects b-catenin expression and its cellular localization.
To this aim, total proteins of HuVECs infected with non-target or MMP8 shRNA lentivirus were extracted and subjected to western blot analyses to detect the expression of b-catenin. Data shown in Figure 4A and B revealed that knockdown endogenous MMP8 in HuVECs slightly decreased b-catenin protein expression. We next performed immunofluorescence staining to evaluate the distribution /well) for 24 h, and images were taken. Representative images (A) and quantitative data (B) of branch length, number, and branch points were presented here, respectively. Data were shown as mean + SEM from three independent experiments (10 images from each group in each experiment were collected to produce the data presented here).
* P , 0.05. of b-catenin in HuVECs. We observed that b-catenin distributed evenly between cell membrane and nuclear in HuVECs infected with non-target shRNA lentivirus, but mainly accumulated in the cell membrane in the HuVECs with MMP8 knockdown (Supplementary material online, Figure S2 ). To further confirm the cellular distributions of b-catenin in HuVECs, cytosolic and nuclear protein were extracted and subjected to western blot analyses. In consistent with the immunofluorescence staining pattern, the levels of nuclear b-catenin in HuVECs infected with MMP8 shRNA lentivirus were significantly decreased, compared with that of control HuVECs ( Figure 4C) , suggesting that knockdown endogenous MMP8 in HuVECs resulted in less b-catenin nuclear accumulation. Once b-catenin disassociates from membrane, it may translocate into nucleus and promote cell proliferation by regulating cell proliferation-related gene expressions such as T-cell factor (TCF) 1B, 1E, FZD7, CCND1, Follistatin, and Id2. Our data showed that the gene expression levels of TCF1B, TCF1E, FZD, and CCND1, but not the follistatin and Id2, were significantly down-regulated by knockdown of MMP8 in HuVECs ( Figure 4D) , suggesting that MMP8 mediates EC proliferation through regulation of these four gene expressions. HuVECs infected with non-target and MMP8 shRNA lentivirus were serum starvation for 12 h, followed by Ang I (10 nM) stimulation for 24 h. The level of PECAM-1 was then determined by western blot analyses. All the bar graph data were represented as mean + SEM from three independent experiments, * P , 0.05.
Knockdown of MMP8 significantly impairs the capacity of in vivo angiogenesis in HuVECs
The above data clearly demonstrated that MMP8 plays an important role in EC angiogenesis by regulating EC migration and proliferation.
To further evaluate the influence of MMP8 knockdown on EC in vivo angiogenesis, HuVECs infected with MMP8 shRNA or nontarget shRNA lentivirus were labelled with PKH26 Red Fluorescent reagent, mixed with Matrigel, and then injected subcutaneouslyinto the backs of mice. After 13 days, Matrigel plugs were harvested, cryosectioned, and subjected to H&E ( Figure 5A and B) and DAPI (Supplementary material online, Figure S3 ) staining, respectively. Consisting with the findings from in vitro capillary-like network formation, we observed a significant decrease in terms of capillary density and vessels numbers in the Matrigel plugs implanted with HuVECs infected with MMP8 shRNA lentivirus, compared with the control group ( Figure 5A and B and Supplementary material online, Figure S3 ). As expected, we also observed that .90% of the cells within Matrigel plugs were labelled with PKH26 Red Fluorescent (Supplementary material online, Figure S3 ), indicating that the new vessels formed in the Matrigel were mainly originated from the injected HuVECs. Importantly, no significantly difference was observed in terms of the PKH26-labelled cells within Matrigel plugs implanted with non-target shRNA or MMP8 shRNA-infected HuVECs (Supplementary material online, Figure S3 ), suggesting that the major contributor for above observed angiogenesis difference between two groups is non-target or MMP8 shRNA lentivirus-infected cell itself. Taken together, above data strongly suggest that MMP8 plays an important role in EC angiogenesis in vitro and in vivo.
MMP8 deficiency inhibits angiogenesis by impairing EC migration and proliferation in vivo
To further discern the importance of MMP8 in endothelial angiogenesis in vivo, 100 mL of Matrigel containing 100 ng/mL VEGF165 were injected sc into wild-type (ApoE 2/2 /MMP8 +/+ ) and MMP8 knockout (ApoE 2/2 /MMP8 2/2 ) mice. Data shown in Figure 5C and D revealed that there was a significant decrease in the number of migrated cells and vessels within the Matrigel plugs injected into the MMP8 knockout mice, compared with that of wild-type mice. Immunofluorescence staining with antibody against EC marker CD144 showed that majority of cells migrated into Matrigel plugs were CD144-positive endothelial cells ( Figure 5E) . Importantly, the percentage of cell proliferation marker Ki-67-positive ECs were significantly higher in wild-type mice than that of MMP8 knockout mice ( Figure 5F ), suggesting that MMP8-deficient ECs had lower migration/proliferation ability and less capacity of angiogenesis. Similarly, the aortic ring assay showed that the aortic rings isolated from MMP8 knockout mice had much lower endothelial sprouting ability than that of the aortic rings isolated from wild-type mice (Supplementary material online, Figure S4 ), further supporting that MMP8 deficiency results in reduced EC migration, proliferation, and angiogenesis.
Inactivating MMP8 significantly reduced lesion size and ECs in the atherosclerotic plaques
It has been shown that MMP8 colocalizes with luminal endothelium, smooth muscle cells, and macrophages in human atherosclerotic plaques, 20 and its expression is enhanced in rapidly progressing plaques. 21 In keeping with these findings, our immunohistochemical staining showed that MMP8 was also expressed in the microvessels within human aneurysm and atherosclerotic plaques (Supplementary material online, Figure S5 ), suggesting that MMP8 may play a role in intraplaque angiogenesis. Our above data provided strong evidence that MMP8 plays an important role in EC angiogenesis under physiological conditions. Moreover, our previous studies confirmed an causal role of MMP8 in atherosclerotic plaque development by converting Ang I to Ang II, modulating vascular cell adhesion molecule 1 (VCAM-1) expression levels, and regulating leucocyte rolling and adhesion on vascular endothelium, 4 as well as mediating stem/progenitor cell recruitment into atherosclerotic plaques; 11 however, no data has been shown if Figure S6 ), which is consistent with our previous data obtained from the whole mount aorta Oil Red O staining. 4 To investigate whether MMP8 played a role in angiogenesis within atherosclerotic lesions, we compared the numbers of endothelial cells in aortic root Figure 6 ). Similar trends were also observed in terms of the numbers of the subjects within ranges (50-500 pixels) which are positive for CD31 ( Figure 6A ) or CD144 ( Figure 6B ). The reduced EC number in the plaques can be the result of reduced plaque size or altered plaque composition in the MMP8-deficient mice. To distinguish these possibilities, CD31-or CD144-positive subjects within plaques were normalized by an atherosclerotic lesion size and presented as CD31-or CD144-positive subjects per 10 5 pixel 2 of the lesion area. Data shown in Figure 6 indicated that the plaque composition was altered in the MMP8-deficient mice. Taken together, these data strongly suggest that MMP8 has a functional involvement in plaque angiogenesis.
Discussion
The findings of the present study provide new insights into the molecular mechanism-mediating endothelial angiogenesis by uncovering an important role of MMP8 in mediating endothelial angiogenesis in vitro and in vivo. Its functional involvement in endothelial angiogenesis was supported by several lines of evidence. First, we observed MMP8 was expressed in the microvessels of human aneurysms and atherosclerotic plaques, and endothelial cell numbers within atherosclerotic plaques of MMP8 knockout mice were much less than that of wildtype mice. Secondly, we demonstrated that knockdown of endogenous MMP8 in HuVECs significantly reduced their capacity of migration, proliferation, capillary-like network formation, and in vivo angiogenesis. Thirdly, our ex vivo aortic ring culturing experiments showed that MMP8-deficient ECs had a lower endothelial cell sprouting ability, compared with the aortic rings isolated from wild-type mice. Finally, by implanting Matrigel containing VEGF165 into mice, we further demonstrated that the host ECs of MMP8 knockout mice displayed a decreased ability to migrate into Matrigel plugs and form vessels-like structures within Matrigel plugs in response to VEGF165 stimulation in vivo. To our knowledge, this is the first report to uncover the functional involvements of MMP8 in angiognesis in vitro and in vivo. Angiogenesis is necessary for many physiological and pathological processes, including embryonic development, wound healing, tissue ischaemia, cancer, and atherosclerosis. 22 It is a complicated process involving endothelial proliferation, migration, remodelling of the ECM, and finally formation of functional new vessels. 1 The initial process of angiogenesis is endothelial sprouting and the first step of endothelial sprouting is the detachment of ECs from the basement membrane, which was regulated by several MMPs. 10 MMP8, also known as collagenase 2 or neutrophil collagenase, has three-fold greater enzyme activity on collagen I than any other MMPs. It has been reported that elevated MMP8 concentrations are related to the unfavourable cardiovascular outcome, 23 and that intraplaque MMP8 levels are higher in asymptomatic patients with carotid plaque progression.
21
MMP8 has been also shown to promote the migration of polymorphonuclear cell and neutrophil. 24, 25 All the existing evidence regarding the functional involvements of MMP8 in atherosclerosis and other inflammatory diseases and its nature in digestion of various ECM and non-ECM proteins prompt us to investigate its function in angiogenesis. In this study, we demonstrated for the first time that MMP8 plays an important role in endothelial angiogenesis by using in vitro, ex vivo, and in vivo angiogenesis assays. An important finding in this study is that PECAM-1 expression was significantly down-regulated after MMP8 knockdown in HuVECs. It has been shown that PECAM-1 participates in a number of biological processes including angiogenesis. 26 In addition to acting as an adhesion protein, increasing evidence shows that PECAM-1 participates in intracellular signal transduction, 27 and promotes endothelial migration. 13 Of note, one study shows that PECAM-1 promotes endothelial cell proliferation by up-regulating b-catenin expression and nuclear accumulation, 19 which is consistent with our findings that HuVECs with knockdown of endogenous MMP8 display significant lower levels of PECAM-1 protein expression ( Figure 3A ) and less b-catenin nuclear accumulation ( Figure 4C and Supplementary material online, Figure S2 ). It is noteworthy that the PECAM-1/CD31 expression level was reduced in HuVECs with MMP8 knockdown, indicating that PECAM-1/CD31 is not an excellent marker for labelling the blood vessels in MMP8-deficient animals ( Figure 6A ). By using another EC-specific marker, CD144, we did observe significant less EC staining within the plaque of MMP8-deficient mice ( Figure 6B ), suggesting that MMP8 does play a role in plaque angiogenesis. Figure 6 Endothelial marker expression levels in atherosclerotic lesions of MMP8 knockout mice were significantly lower than that of wild-type control mice. Both ApoE 2/2 /MMP8 +/+ and ApoE 2/2 /MMP8 2/2 mice were fed a Western diet for 12 weeks. Sections of the aortic roots were subjected to immunohistochemistry staining with antibodies against PECAM-1/CD31 (A) and VE-cadherin/CD144 (B). Left panels are representative images of the aortic roots with immunohistochemistry staining. Right panels are quantitative data of the percentage of the EC-specific marker staining area and the numbers of the subjects within ranges (50 -500 pixels) positive for EC markers in atherosclerotic lesions, respectively. Additional sections with normal IgG substituted for the respective primary antibody were included as a negative control. Columns represent mean + SEM (n ¼ 7 mice, 4 sections per mice, in each group), *P , 0.05.
Further identifying the underlying molecular mechanisms by which how MMP8-mediated PECAM-1 protein expression in HuVECs is crucial for us to fully understand the functional involvements of MMP8 in endothelial angiogenesis. For this purpose, we turned our interest to Ang I/II convention because Ang II has been implicated in atherosclerosis progression 14 and angiogenesis. 15 Apart from angiotensin-converting enzyme, other enzyme such as MMP8 has also been shown to cleave Ang I to produce Ang II. 16 Importantly, our previous study showed that MMP8 knockout mice had higher plasma Ang I levels, but lower plasma Ang II levels. 4 On the other hand, another study reported that PECAM-1 protein expression levels were significantly up-regulated by Ang II-induced endothelial microparticle in HuVECs. 17 In line with these findings, we found that Ang II could significantly up-regulate PECAM-1 protein expression levels in HuVECs infected with both non-target shRNA and MMP-8 shRNA lentivirus. Strikingly, Ang I could only significantly enhance PECAM-1 expression in HuVECs infected with non-target shRNA, indicating that Ang II converted from Ang I by MMP8 was at least partially responsible for the up-regulation of PECAM-1 in HuVECs. However, future works to further explore the underlying molecular mechanisms by which how Ang II mediates PECAM-1 protein expression in HuVECs would be warranted. In summary, based on the findings in the present study and from previous studies, we proposed that MMP8 exerts its important function in endothelial angiogenesis by converting Ang I to Ang II, which in turn increases PECAM-1 expression, promotes b-catenin nuclear accumulation and up-regulates cell proliferation/migration-related gene expression. Our findings may provide new insights into the mechanisms of intraplaque angiogenesis during the development of atherosclerosis, and a potential therapeutic target of cardiovascular diseases.
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